These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 14680786)
1. [Revelation of a polymicrocystic ovary syndrome after one month's treatment by pulsatile GnRH in a patient presenting with functional hypothalamic amenorrhea]. Reyss AC; Merlen E; Demerle C; Dewailly D Gynecol Obstet Fertil; 2003 Dec; 31(12):1039-42. PubMed ID: 14680786 [TBL] [Abstract][Full Text] [Related]
2. Endocrine dynamics during pulsatile GnRH administration in patients with hypothalamic amenorrhea and polycystic ovarian disease. Rossmanith WG; Wirth U; Benz R; Wolf AS Gynecol Endocrinol; 1989; 3(1):21-34. PubMed ID: 2658471 [TBL] [Abstract][Full Text] [Related]
3. Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea. Mattle V; Bilgyicildirim A; Hadziomerovic D; Ott HW; Zervomanolakis I; Leyendecker G; Wildt L Fertil Steril; 2008 Feb; 89(2):404-9. PubMed ID: 17583701 [TBL] [Abstract][Full Text] [Related]
4. Comparison between pulsatile GnRH therapy and gonadotropins for ovulation induction in women with both functional hypothalamic amenorrhea and polycystic ovarian morphology. Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G Gynecol Endocrinol; 2016 Dec; 32(12):999-1004. PubMed ID: 27258574 [TBL] [Abstract][Full Text] [Related]
5. Prospective, randomized comparison between pulsatile GnRH therapy and combined gonadotropin (FSH+LH) treatment for ovulation induction in women with hypothalamic amenorrhea and underlying polycystic ovary syndrome. Dubourdieu S; Fréour T; Dessolle L; Barrière P Eur J Obstet Gynecol Reprod Biol; 2013 May; 168(1):45-8. PubMed ID: 23298894 [TBL] [Abstract][Full Text] [Related]
6. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders. Saffan D; Seibel MM Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681 [TBL] [Abstract][Full Text] [Related]
7. The induction of ovulation by pulsatile administration of GnRH: an appropriate method in hypothalamic amenorrhea. Christou F; Pitteloud N; Gomez F Gynecol Endocrinol; 2017 Aug; 33(8):598-601. PubMed ID: 28277105 [TBL] [Abstract][Full Text] [Related]
8. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction. Filicori M; Flamigni C; Cognigni G; Dellai P; Michelacci L; Arnone R Fertil Steril; 1994 Aug; 62(2):279-85. PubMed ID: 8034073 [TBL] [Abstract][Full Text] [Related]
10. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835 [TBL] [Abstract][Full Text] [Related]
11. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea. Couzinet B; Young J; Brailly S; Chanson P; Schaison G J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262 [TBL] [Abstract][Full Text] [Related]
12. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487 [TBL] [Abstract][Full Text] [Related]
13. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease]. Kuroda G Nihon Naibunpi Gakkai Zasshi; 1987 Mar; 63(3):247-59. PubMed ID: 3111899 [TBL] [Abstract][Full Text] [Related]
14. Increased anti-Mullerian hormone levels and ovarian size in a subgroup of women with functional hypothalamic amenorrhea: further identification of the link between polycystic ovary syndrome and functional hypothalamic amenorrhea. Carmina E; Fruzzetti F; Lobo RA Am J Obstet Gynecol; 2016 Jun; 214(6):714.e1-6. PubMed ID: 26767792 [TBL] [Abstract][Full Text] [Related]
17. Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: a pilot prospective study. Fulghesu AM; Ciampelli M; Belosi C; Apa R; Guido M; Caruso A; Mancuso S; Lanzone A J Endocrinol Invest; 2001; 24(7):483-90. PubMed ID: 11508781 [TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone for infertility in women with primary hypothalamic amenorrhea. Toward a more-interventional approach. Kesrouani A; Abdallah MA; Attieh E; Abboud J; Atallah D; Makhoul C J Reprod Med; 2001 Jan; 46(1):23-8. PubMed ID: 11209627 [TBL] [Abstract][Full Text] [Related]
19. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Adams J; Franks S; Polson DW; Mason HD; Abdulwahid N; Tucker M; Morris DV; Price J; Jacobs HS Lancet; 1985 Dec 21-28; 2(8469-70):1375-9. PubMed ID: 2867389 [TBL] [Abstract][Full Text] [Related]
20. Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. Bayram N; van Wely M; Vandekerckhove P; Lilford R; van Der Veen F Cochrane Database Syst Rev; 2000; (2):CD000412. PubMed ID: 10796718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]